137 related articles for article (PubMed ID: 10673371)
21. Mechanisms of the inhibitory effect of epigallocatechin-3-gallate on cultured human vascular smooth muscle cell invasion.
Cheng XW; Kuzuya M; Nakamura K; Liu Z; Di Q; Hasegawa J; Iwata M; Murohara T; Yokota M; Iguchi A
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1864-70. PubMed ID: 16051878
[TBL] [Abstract][Full Text] [Related]
22. Differential roles of TIMP-4 and TIMP-2 in pro-MMP-2 activation by MT1-MMP.
Hernandez-Barrantes S; Shimura Y; Soloway PD; Sang QA; Fridman R
Biochem Biophys Res Commun; 2001 Feb; 281(1):126-30. PubMed ID: 11178970
[TBL] [Abstract][Full Text] [Related]
23. Activation of membrane-type matrix metalloproteinase 3 zymogen by the proprotein convertase furin in the trans-Golgi network.
Kang T; Nagase H; Pei D
Cancer Res; 2002 Feb; 62(3):675-81. PubMed ID: 11830519
[TBL] [Abstract][Full Text] [Related]
24. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes.
Baumann P; Zigrino P; Mauch C; Breitkreutz D; Nischt R
Br J Cancer; 2000 Nov; 83(10):1387-93. PubMed ID: 11044366
[TBL] [Abstract][Full Text] [Related]
25. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study.
Butler GS; Butler MJ; Atkinson SJ; Will H; Tamura T; Schade van Westrum S; Crabbe T; Clements J; d'Ortho MP; Murphy G
J Biol Chem; 1998 Jan; 273(2):871-80. PubMed ID: 9422744
[TBL] [Abstract][Full Text] [Related]
26. Expression pattern of four membrane-type matrix metalloproteinases in the normal and diseased mouse mammary gland.
Szabova L; Yamada SS; Birkedal-Hansen H; Holmbeck K
J Cell Physiol; 2005 Oct; 205(1):123-32. PubMed ID: 15895410
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice.
Ha HY; Moon HB; Nam MS; Lee JW; Ryoo ZY; Lee TH; Lee KK; So BJ; Sato H; Seiki M; Yu DY
Cancer Res; 2001 Feb; 61(3):984-90. PubMed ID: 11221894
[TBL] [Abstract][Full Text] [Related]
28. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases.
Butler GS; Will H; Atkinson SJ; Murphy G
Eur J Biochem; 1997 Mar; 244(2):653-7. PubMed ID: 9119036
[TBL] [Abstract][Full Text] [Related]
29. Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors.
Ueda J; Kajita M; Suenaga N; Fujii K; Seiki M
Oncogene; 2003 Nov; 22(54):8716-22. PubMed ID: 14647466
[TBL] [Abstract][Full Text] [Related]
30. Interactions of gelatinases with soluble and immobilized fetuin and asialofetuin.
Ochieng J; Warfield P; Green B
Arch Biochem Biophys; 1995 Sep; 322(1):250-5. PubMed ID: 7574683
[TBL] [Abstract][Full Text] [Related]
31. Perivascular cells regulate endothelial membrane type-1 matrix metalloproteinase activity.
Lafleur MA; Forsyth PA; Atkinson SJ; Murphy G; Edwards DR
Biochem Biophys Res Commun; 2001 Mar; 282(2):463-73. PubMed ID: 11401482
[TBL] [Abstract][Full Text] [Related]
32. Experimental hindlimb ischemia leads to neutrophil-mediated increases in gastrocnemius MMP-2 and -9 activity: a potential mechanism for ischemia induced MMP activation.
Muhs BE; Gagne P; Plitas G; Shaw JP; Shamamian P
J Surg Res; 2004 Apr; 117(2):249-54. PubMed ID: 15047130
[TBL] [Abstract][Full Text] [Related]
33. Anti-alpha2 integrin antibody induces secretion and activation of 72-kDa progelatinase by human fibroblasts.
Ishibashi Y; Ito H; Seyama Y; Kubota S
IUBMB Life; 2001 Jan; 51(1):25-31. PubMed ID: 11419692
[TBL] [Abstract][Full Text] [Related]
34. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
[TBL] [Abstract][Full Text] [Related]
35. Membrane independent activation of fibroblast proMMP-2 by snake venom: novel roles for venom proteinases.
Saravia-Otten P; Frisan T; Thelestam M; Gutiérrez JM
Toxicon; 2004 Dec; 44(7):749-64. PubMed ID: 15500851
[TBL] [Abstract][Full Text] [Related]
36. The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2.
Lichte A; Kolkenbrock H; Tschesche H
FEBS Lett; 1996 Nov; 397(2-3):277-82. PubMed ID: 8955363
[TBL] [Abstract][Full Text] [Related]
37. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin.
Jo M; Thomas LE; Wheeler SE; Curry TE
Biol Reprod; 2004 Apr; 70(4):1024-32. PubMed ID: 14668206
[TBL] [Abstract][Full Text] [Related]
38. Furin-dependent intracellular activation of the human stromelysin-3 zymogen.
Pei D; Weiss SJ
Nature; 1995 May; 375(6528):244-7. PubMed ID: 7746327
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the role of the "MT-loop": an eight-amino acid insertion specific to progelatinase A (MMP2) activating membrane-type matrix metalloproteinases.
English WR; Holtz B; Vogt G; Knäuper V; Murphy G
J Biol Chem; 2001 Nov; 276(45):42018-26. PubMed ID: 11555661
[TBL] [Abstract][Full Text] [Related]
40. Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain.
Cao J; Rehemtulla A; Bahou W; Zucker S
J Biol Chem; 1996 Nov; 271(47):30174-80. PubMed ID: 8939968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
